Drawing for PHASIFY

USPTO serial 88369066

PHASIFY

Reviewed by CopyMark Law Group

Reg. 6219329Status 700Renewal
Filing date
Status date
Registration date
Dec 15, 2020
Examiner
KUNKLEMAN, SARAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHASIFY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura M. Konkel

Laura M. Konkel Michael Best & Friedrich LLP790 N Water Street, Suite 2500Milwaukee, WI 53202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biological preparations for use in industry and science; Chemical test kits for the expression, amplification, purification and analysis of biological samples for laboratory or research use; Chemicals for use in industry and science; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Reagents for scientific and research use; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposesACTIVE—
005Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, pregnancy; Chemical preparations for pharmaceutical or medical purposes, namely, for infectious diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases; Diagnostic preparations for medical or veterinary purposes; Medical diagnostic reagents and assays for testing of body fluids; Veterinary diagnostic reagentsACTIVE—
009Bio-chips for research or scientific purposes; Laboratory apparatus and instruments for extracting nucleic acid, DNA, RNA, exosome, other biomarkers; Medical laboratory research instruments for preparation, modification and manipulation of samples containing biopolymers, namely, nucleic acids, proteins, and biomarkers; Medical laboratory research instruments for the separation, isolation, purification, and analysis of biopolymers, namely, nucleic acids, proteins, and biomarkers; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; Scientific instrumentation for measuring relative concentration of an analyte in a fluid not for medical useACTIVE—
010Diagnostic apparatus for the detection of cancer; Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic usesACTIVE—
042Chemical, biochemical, biological and bacteriological research and analysis; Consulting services for others in the field of design, planning, and implementation project management of scientific research, analysis, and testing in the field of chemistry, genetics, biology and biochemistry; DNA analysis services for scientific research purposes; Research and development and consultation related thereto in the field of chemistry, genetics, biology and biochemistry; Scientific and technological services, namely, research and design in the field of biology, biomedicine, and biotechnology, molecular diagnostics and molecular medicine; Custom design and development of chemical reagents and biochemical assaysACTIVE—
044Medical diagnosis of human diseases, namely, genetic, infectious, neurological, cardiovascular, cancerous, inflammatory, reproductive and developmental diseases; Medical diagnosis of ovary cancer, liver cancer, stomach cancer, pancreas cancer, esophagus cancer, colorectum cancer, lung cancer, or breast cancer; Medical diagnostic testing, monitoring and reporting servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 15, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 16, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 16, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 28, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 28, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 15, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 29, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 24, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 10, 2020ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Aug 10, 2020PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Aug 5, 2020ERTITEAS RESPONSE TO PETITION INQUIRY LETTER—
Aug 4, 2020PILMPETITION INQUIRY LETTER ISSUED—
Jul 27, 2020APETASSIGNED TO PETITION STAFF—
Jul 20, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 2, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jun 2, 2020TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Mar 17, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 13, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 13, 2020EXT1SOU EXTENSION 1 FILED—
Mar 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 11, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 11, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 11, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 11, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 12, 2019DOCKASSIGNED TO EXAMINER—
Sep 17, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 23, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 23, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 13, 2019DOCKASSIGNED TO EXAMINER—
Apr 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 6, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance